Hedgehog lipoprotein(a) is a modulator of activation of plasminogen at the fibrin surface. An in vitro study.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Arteriosclerosis and Thrombosis A Journal of Vascular Biology

• Publication date

  1992-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1161/01.ATV.12.2.146PMID 1531929
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines.

  1991cited by this paper
• Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu.

  1991cited by this paper
• Lipoprotein(a) inhibition of plasminogen activation by tissue-type plasminogen activator.

  1990cited by this paper
• Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age.

  1990cited by this paper
• The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.

  1990cited by this paper
• Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin.

  1989cited by this paper
• Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis.

  1989cited by this paper
• Seasonal variations of plasma lipids and lipoproteins in the hedgehog, an animal model for lipoprotein (a) metabolism: relation to plasma thyroxine and testosterone levels.

  1989cited by this paper
• Lipoprotein(a): A Genetically Determined Lipoprotein Containing a Glycoprotein of the Plasminogen Family

  1988cited by this paper
• Lipoprotein[a] is the major apoB-containing lipoprotein in the plasma of a hibernator, the hedgehog (Erinaceus europaeus).

  1988cited by this paper
• Kinetic analysis of the interaction between plasminogen activator inhibitor-1 and tissue-type plasminogen activator.

  1988cited by this paper
• Lipoprotein(a). A potential bridge between the fields of atherosclerosis and thrombosis.

  1988cited by this paper
• Lipoprotein(a). A potential bridge between the fields of atherosclerosis and thrombosis.

  1988cited by this paper
• cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

  1987cited by this paper
• Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen.

  1987cited by this paper
• A spectrophotometric solid-phase fibrin-tissue plasminogen activator activity assay (SOFIA-tPA) for high-fibrin-affinity tissue plasminogen activators.

  1986cited by this paper
• Nondenaturing polyacrylamide gradient gel electrophoresis.

  1986cited by this paper
• Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a).

  1985influential reference
• A monoclonal antibody, specific for human fibrinogen, fibrinopeptide A-containing fragments and not reacting with free fibrinopeptide A.

  1985cited by this paper
• Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis.

  1984cited by this paper
• Heterogeneity of plasminogen activator expression in various moloney virus‐induced tumor cell lines. Lack of correlation with tumor growth and cell phenotype

  1984cited by this paper
• On the role of the carbohydrate side chains of human plasminogen in its interaction with alpha 2-antiplasmin and fibrin.

  1981cited by this paper
• Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein.

  1980cited by this paper
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

  1979cited by this paper
• Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

  1978cited by this paper
• Particle distribution of human serum high density lipoproteins.

  1977cited by this paper
• Binding of soluble form of fibroblast surface protein, fibronectin, to collagen

  1977cited by this paper
• Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate.

  1977cited by this paper
• Plasminogen: Purification from Human Plasma by Affinity Chromatography

  1970cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Immunochemical quantitation of antigens by single radial immunodiffusion.

  1965cited by this paper
• The Preparation and Some Properties of Fibrinogen Precipitated from Human Plasma by Glycine.∗

  1963cited by this paper
• CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography

  year unknowncited by this paper

• Lipoprotein(a): Structure, Metabolism, and Pathophysiology

  2014cites this paper
• Human plasminogen kringle 3: solution structure, functional insights, phylogenetic landscape.

  2010cites this paper
• Identification and Characterization of Novel Lysine-independent Apolipoprotein(a)-binding Sites in Fibrin(ogen) αC-domains*

  2003cites this paper
• Identification of a Novel Apolipoprotein(a)-related Protein from the European Hedgehog ( Erinaceus europaeus )

  2003cites this paper
• Identification and characterization of novel lysine-independent apolipoprotein(a)-binding sites in fibrin(ogen) alphaC-domains.

  2003cites this paper
• Lipoproteína (a), ¿es un factor de riesgo en la enfermedad aterotrombótica coronaria?

  2001cites this paper
• Lipoprotein Lp(a) and atherothrombotic disease.

  2000cites this paper
• Thrombosis in the Pathogenesis of Coronary Artery Disease

  1998cites this paper
• Plasma Lipoproteins and Coronary Heart Disease

  1998cites this paper
• Convergent evolution of apolipoprotein(a) in primates and hedgehog.

  1997cites this paper
• The lysine‐binding function of Lp(a)

  1997cites this paper
• Genetic variation in factor VII associated with variation in plasma lipoprotein(a) concentration.

  1997cites this paper
• Genetic Variation in Factor VII Associated with Variation in Plasma Lipoprotein(a) Concentration

  1997cites this paper
• Lipoprotein [a].

  1996cites this paper
• How often has Lp(a) evolved?

  1996cites this paper
• Fibrinolytic status of the normal human fetus: association with undetectable levels of histidin-rich glycoprotein and lipoprotein(a)

  1996cites this paper
• The influence of 6AHA and α2-antiplasmin on the fibrinolysis in normal, Pg-deficient and (Pg + α2-antiplasmin)-deficient plasmas studied by turbidimetric method

  1996cites this paper
• The Recurring Evolution of Lipoprotein(a)

  1995cites this paper
• Association of lipoprotein(a) with atherothrombotic events and fibrinolytic variables. A case-control study.

  1995cites this paper
• Relationships of plasminogen activator inhibitor activity and lipoprotein(a) with insulin, testosterone, 17 beta-estradiol, and testosterone binding globulin in myocardial infarction patients and healthy controls.

  1995cites this paper
• Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator.

  1994cites this paper
• Lipid-thrombosis interface.

  1994cites this paper
• Rhesus monkey lipoprotein(a) binds to lysine Sepharose and U937 monocytoid cells less efficiently than human lipoprotein(a). Evidence for the dominant role of kringle 4(37).

  1993cites this paper
• The coagulation and fibrinolysis systems and atherosclerosis.

  1993cites this paper
• A 2-year study on the beneficial effects of 17 beta-oestradiol-dydrogesterone therapy on serum lipoproteins and Lp(a) in postmenopausal women: no additional unfavourable effects of dydrogesterone.

  1993cites this paper